Number of Cancer Survivors May Reach Approximately 18 Million by 2022

This article originally appeared here.
Share this content:
Number of Cancer Survivors May Reach ~18 Million by 2022
Number of Cancer Survivors May Reach ~18 Million by 2022

(HealthDay News) – Based on current trends and treatment patterns, the estimated number of cancer survivors in the United States is likely to increase to nearly 18 million by Jan. 1, 2022, according to a report published online June 14 in CA: A Cancer Journal for Clinicians.

To understand the unique medical and psychosocial needs of cancer survivors, Rebecca Siegel, MPH, from the American Cancer Society in Atlanta, and colleagues estimated the prevalence of cancer survivors on January 1, 2012, and January 1, 2022, by cancer site. Median age and stage at diagnosis and survival were extracted from the Surveillance, Epidemiology, and End Results (SEER) registries; and patterns of cancer treatment were described using the National Cancer Data Base and the SEER-Medicare Databases.

The researchers estimated that 13.7 million Americans with a history of cancer were alive on Jan. 1, 2012, and that this number would increase to nearly 18 million by Jan. 1, 2022. For males, the three most prevalent cancers were found to be prostate, colorectal, and melanoma of the skin, while for females the three most prevalent cancers were breast, uterine corpus, and colorectal cancer.

"This article summarizes common cancer treatments, survival rates, and post-treatment concerns and introduces the new National Cancer Survivorship Resource Center, which has engaged more than 100 volunteer survivorship experts nationwide to develop tools for cancer survivors, caregivers, health care professionals, advocates, and policy makers," the authors write.

Full Text

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs